These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation. Ahrens MJ, Berry SA, Whitley CB, Markowitz DJ, Plante RJ, Tuchman M. Am J Med Genet; 1996 Dec 18; 66(3):311-5. PubMed ID: 8985493 [Abstract] [Full Text] [Related]
13. [Changes of urinary excretion of orotic acid in a patient with ornithine carbamyl transferase deficiency]. Sakane Y, Sugimoto T. Rinsho Byori; 1982 May 04; 30(5):547-50. PubMed ID: 7131821 [No Abstract] [Full Text] [Related]
14. A novel missense mutation in the exon containing the putative ornithine-binding domain of the OTC enzyme in a female. Demmer LA, Kim JM, de Martinville B, Dowton SB. Hum Mutat; 1996 May 04; 7(3):279. PubMed ID: 8829665 [No Abstract] [Full Text] [Related]
15. Spontaneous animal models of ornithine transcarbamylase deficiency: studies on serum and urinary nitrogenous metabolites. Qureshi IA, Letarte J, Ouellet R. Adv Exp Med Biol; 1982 May 04; 153():173-83. PubMed ID: 7164896 [No Abstract] [Full Text] [Related]
16. [Variability of enzyme activity and urinary orotic acid in ornithine transcarbamylase deficient spf/+ heterozygotic mice]. Qureshi IA, Letarte J, Lebel S, Ouellet R. Diabete Metab; 1986 Oct 04; 12(5):250-5. PubMed ID: 3803679 [Abstract] [Full Text] [Related]
17. Identification of a cytogenetic deletion and of four novel mutations (Q69X, I172F, G188V, G197R) affecting the gene for ornithine transcarbamylase (OTC) in Spanish patients with OTC deficiency. Climent C, García-Pérez MA, Sanjurjo P, Ruiz-Sanz JI, Vilaseca MA, Pineda M, Campistol J, Rubio V. Hum Mutat; 1999 Oct 04; 14(4):352-3. PubMed ID: 10502831 [Abstract] [Full Text] [Related]
19. Prenatal monitoring in a family at high risk for ornithine transcarbamylase (OTC) deficiency: a new mutation of an A-to-C transversion in position +4 of intron 1 of the OTC gene that is likely to abolish enzyme activity. Hoshide R, Matsuura T, Sagara Y, Kubo T, Shimadzu M, Endo F, Matsuda I. Am J Med Genet; 1996 Aug 23; 64(3):459-64. PubMed ID: 8862622 [Abstract] [Full Text] [Related]